Concepedia

Dennis Dentoni-Lasofsky

DD

Statistics

Publications

3

Citations

99

H-Index

3

Active since

2018

Affiliations

Harvard University(Current)

UCLA Medical Center

National Institutes of Health

University of California San Diego

Brigham and Women's Hospital

Dennis Dentoni-Lasofsky is an author at Harvard University specializing in placebo comparators, monoclonal antibodies, and post-exposure prophylaxis.

Publications per year

2018–2023

3

Publications

3

Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California

Julia L. Marcus, Leo B. Hurley, Dennis Dentoni-Lasofsky et al. · AIDS Care · 2018 · 56 citations · Full text

, , +17

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Teresa H. Evering, Mark J Giganti, Carlee Moser et al. · Annals of Internal Medicine · 2023 · 31 citations · Full text

, , +17

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

Prasanna Jagannathan, Kara W Chew, Mark J Giganti et al. · EClinicalMedicine · 2023 · 12 citations · Full text

, , +14

1–3 of 3